-
Nightly melatonin improved objective and subjective sleep quality in a small number of patients who were taking beta-blockers for hypertension.
-
The FDA has approved an ethyl ester of eicosapentaenoic acid (EPA) to treat hypertriglyceridemia. It is the second drug in this class after Lovaza, which contains esters of both EPA and DHA (docosahexaenoic acid). Icosapent ethyl is marketed by Amarin Pharmaceuticals, a Dublin, Ireland-based company, as Vascepa.
-
Scenario: The lead II rhythm strip shown above was observed on telemetry. Is the patient in atrial flutter?
-
-
Quality-of-life Effects of PSA Screening; Secondary Prevention of Lacunar Stroke; PSA Elevations After Prostate Cancer Radiotherapy
-
In a nursing home-eligible population with a mean age of 80, those with a HbA1c between 8% and 8.9% had less functional decline than those with a HbA1c of 7% to 7.9%.
-
Evidence-based spiritual assessment tools are presented in this manuscript, which open a dialogue between patients and physicians. These adjunctive therapeutic interventions have been found to improve outcomes for patients with depression, cardiovascular disease, pain, anxiety, and adolescent risk behaviors.
-
Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions.
-
At the June 20, 2012 meeting in Atlanta, Georgia the CDC Advisory Committee on Immunization Practices [ACIP] voted in favor of recommending the addition of 13-valent pneumococcal conjugate vaccine (PCV13) to the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for adults aged 19 and older with immunocompromising conditions.
-
Uwanyiligira et al retrospectively analyzed charts of all patients seen at the Travel Clinic of the University Hospital in Lausanne, Switzerland, for rabies post-exposure prophylaxis (PEP) between January 2005 and August 2011.
